69
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Inhaled corticosteroids might not increase the risk of pneumonia in patients with chronic obstructive pulmonary disease in Japan

, , , &
Pages 3503-3509 | Published online: 23 Oct 2018

References

  • Global Initiative for Chronic Obstructive Lung DiseaseThe Global Strategy for the Diagnosis, Management and Prevention of COPDGlobal Initiative for Chronic Obstructive Lung Disease (GOLD)2017 Available from: http://goldcopd.orgAccessed December 15, 2017
  • SzafranskiWCukierARamirezAEfficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary diseaseEur Respir J2003211748112570112
  • MagnussenHDisseBRodriguez-RoisinRWithdrawal of inhaled glucocorticoids and exacerbations of COPDN Engl J Med2014371141285129425196117
  • KunzLIZPostmaDSKloosterKRelapse in FEV1 decline after steroid withdrawal in COPDChest2015148238939625836351
  • LipsonDABarnhartFBrealeyNOnce-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPDN Engl J Med2018378181671168029668352
  • CrimCCalverleyPMAndersonJAPneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study resultsEur Respir J200934364164719443528
  • CalverleyPMStockleyRASeemungalTAInvestigating New Standards for Prophylaxis in Reduction of Exacerbations (INSPIRE) Investigators. Reported pneumonia in patients with COPD: findings from the INSPIRE studyChest2011139350551220576732
  • WelteTMiravitllesMHernandezPEfficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2009180874175019644045
  • SinDDTashkinDZhangXBudesonide and the risk of pneumonia: a meta-analysis of individual patient dataLancet2009374969171271919716963
  • O’ByrnePMPedersenSCarlssonLGRisks of pneumonia in patients with asthma taking inhaled corticosteroidsAm J Respir Crit Care Med2011183558959520889908
  • JansonCLarssonKLisspersKHPneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist: observational matched cohort study (PATHOS)BMJ2013346f330623719639
  • InoueASaijoYMaemondoMSevere acute interstitial pneumonia and gefitinibLancet2003361935213713912531582
  • KohnoSSekiMWatanabeACAP Study GroupEvaluation of an assessment system for the JRS 2005: A-DROP for the management of CAP in adultsIntern Med201150111183119121628933
  • IchinoseMTaniguchiHTakizawaAThe efficacy and safety of combined tiotropium and olodaterol via the Respimat(®) inhaler in patients with COPD: results from the Japanese sub-population of the Tonado(®) studiesInt J Chron Obstruct Pulmon Dis2016112017202727621608
  • KewKMSeniukovichAInhaled steroids and risk of pneumonia for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20143CD010115
  • VestboJPrescottEAlmdalTBody mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart StudyAm J Respir Crit Care Med20061731798316368793
  • YamauchiYYasunagaHHasegawaWEffect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPDInt J Chron Obstruct Pulmon Dis2016111403141127382276